CuS@BSA-NB2 Nanoparticles for HER2-Targeted Photothermal Therapy. PMID: 35126119
An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants. PMID: 35140196
The Remarkable Nb2(CO)12 with Seven-Coordinate Niobium: Decarbonylation to Nb2(CO)11 and Nb2(CO)10. PMID: 26606483
Prospectively Isolated Tetraspanin+ Neoblasts Are Adult Pluripotent Stem Cells Underlying Planaria Regeneration. PMID: 29906446
Tailored Hydrogel Delivering Niobium Carbide Boosts ROS-Scavenging and Antimicrobial Activities for Diabetic Wound Healing. PMID: 35678523
Pyrene-Bridged Expanded Carbaporphyrin Nanobelts. PMID: 35358383
MXene-Derived Ferroelectric Crystals. PMID: 30762903
Ascorbic acid recycling in Nb2 lymphoma cells: implications for tumor progression. PMID: 9890649
Inhibition by genistein of prolactin-induced Nb2 lymphoma cell mitogenesis. PMID: 8143910
Bioassay of hormones. PMID: 6141990
Luminescence properties of red-emission Mg4 Nb2 O9:Eu3+ phosphor. PMID: 25044972
Nb2 dimer: Examination of singlet or triplet character. PMID: 9947775
Anti-proliferative effects of deflazacort on Nb2 cells as quantitated by formazan production. PMID: 7968262
The Quest for Metal-Metal Quadruple and Quintuple Bonds in Metal Carbonyl Derivatives: Nb2(CO)9 and Nb2(CO)8. PMID: 26593348
A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor. PMID: 1718958
Stimulation of growth of Nb2 lymphoma cells by interleukin-2 in serum-free and serum-containing media. PMID: 3258574
Increased cystine uptake capability associated with malignant progression of Nb2 lymphoma cells. PMID: 9264389
The Nb2 form of prolactin receptor is able to activate a milk protein gene promoter. PMID: 1406702
Differential signal transduction of the short, Nb2, and long prolactin receptors. Activation of interferon regulatory factor-1 and cell proliferation. PMID: 7929319
Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression. PMID: 9867250
The role of G-proteins in the mitogenesis of rat lactogen-dependent and lactogen-independent Nb2 lymphoma cells. PMID: 2155099
Novel High Current-Carrying Quasi-1D Material: Nb2 PdS6. PMID: 36323611
Malignant progression of rat Nb2 lymphoma cells: chromosomal alterations and metastatic properties. PMID: 10214359
Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lymphoma cells. PMID: 7588268
Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disorders. PMID: 9972677
A serum-free medium for culturing lactogen dependent and autonomous NB2 node lymphoma cells. PMID: 3552636
Amiloride-sensitive Na+/H+ exchange in rat NB2 node lymphoma cells. Stimulation by prolactin and other mitogens. PMID: 2820701
Nb2 CTx MXene Derived Polymorphic Nb2 O5. PMID: 36950747
The nuclear prolactin receptor: a 62-kDa chromatin-associated protein in rat Nb2 lymphoma cells. PMID: 7574727
Effects of specific fatty acids on prolactin-induced NB2 lymphoma cell proliferation. PMID: 8505862
Modulation of prolactin-stimulated Nb2 lymphoma cell mitogenesis by cholera toxin and pertussis toxin. PMID: 3383778
Phosphorylation of cbl after stimulation of Nb2 cells with prolactin and its association with phosphatidylinositol 3-kinase. PMID: 9259313
Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells. PMID: 8940371
Changes in glutathione redox cycling and oxidative stress response in the malignant progression of NB2 lymphoma cells. PMID: 9639394
Heat-induced proteolysis of HSF causes premature deactivation of the heat shock response in Nb2 lymphoma cells. PMID: 9585182
Bioactivity of macroprolactin in the Nb2 bioassay may be explained by dissociation yielding bioactive monomeric prolactin. PMID: 17651450
Comparison of Nb2 lymphoma cell bioassay with immunoassay for human prolactin: the role of estrogen. PMID: 1512421
Nb2 cell mitogenesis: effect of lactogens on cAMP and protein phosphorylation. PMID: 2469479
Manipulate intestinal organoids with niobium carbide nanosheets. PMID: 32506610
Prolactin-stimulated mitogenesis in the Nb2 rat lymphoma cell: lack of protoporphyrin IX effects. PMID: 2174491
The Influence of the Shoe over the Medial Foot Arch and the Lower Limbs Kinematics in Toddlers. PMID: 35198125
A specific binding site in Nb2 node lymphoma cells mediates the effects of didemnin B, an immunosuppressive cyclic peptide. PMID: 1582735
Fibroblast growth factor-2 stimulates endothelial nitric oxide synthase expression and inhibits apoptosis by a nitric oxide-dependent pathway in Nb2 lymphoma cells. PMID: 11145569
Stathmin gene expression in mammary gland and in Nb2 cells. PMID: 8785512
Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. PMID: 7515493
Growth and protein phosphorylation in the Nb2 lymphoma: effect of prolactin, cAMP, and agents that activate adenylate cyclase. PMID: 2168897
The MEK inhibitor PD 098059 inhibits prolactin-induced Nb2 cell mitogenesis but not milk product synthesis in cultured mouse mammary tissues. PMID: 9824684
Thymic origin of the prolactin-dependent Nb2 lymphoma cell line. PMID: 7046917
Polyclonal antibodies against the NB1-bearing 58- to 64-kDa glycoprotein of human neutrophils do not identify an NB2-bearing molecule. PMID: 8488543
A novel heat shock response in prolactin-dependent Nb2 node lymphoma cells. PMID: 7494006
A Luminescence-Based Method for In Vitro Screening of Immunomodulatory Checkpoints and Therapeutics., PMID:40402459
Immunization with recombinant HPV16-E7d in fusion with Flagellin as a cancer vaccine: Effect of antigen-adjuvant orientation on the immune response pattern., PMID:39939497
Development and evaluation of a novel E7 multi-epitopic vaccine for human papillomavirus type 16: design, expression, purification, and immunological characterization., PMID:39910471
HPV16 mutant E6/E7 construct is protective in mouse model., PMID:39350162
MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2., PMID:38461243
Evaluation of HPV 16 and HPV 18 Oncoprotein Expression as Alternative Diagnostic Tools in Cervical Lesion., PMID:38415538
A Therapeutic DNA Vaccine Targeting HPV16 E7 in Combination with Anti-PD-1/PD-L1 Enhanced Tumor Regression and Cytotoxic Immune Responses., PMID:37895145
Skin-Grafting and Dendritic Cell "Boosted" Humanized Mouse Models Allow the Pre-Clinical Evaluation of Therapeutic Cancer Vaccines., PMID:37626903
A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for in vitro screening of immunomodulatory checkpoints and therapeutics., PMID:37559730
HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women., PMID:35351184
Immunohistochemical Detection of Human Papillomavirus 16 E7 Oncoprotein in Cervical Lesions., PMID:34729114
Targeting Human Papillomavirus-Associated Cancer by Oncoprotein-Specific Recombinant Antibodies., PMID:34502053
Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers., PMID:34432728
Antigen Delivery to DEC205+ Dendritic Cells Induces Immunological Memory and Protective Therapeutic Effects against HPV-Associated Tumors at Different Anatomical Sites., PMID:34345218
Serum HPV16 E7 Oncoprotein Is a Recurrence Marker of Oropharyngeal Squamous Cell Carcinomas., PMID:34282779
Enhancing immunogenicity of HPV16 E7 DNA vaccine by conjugating codon-optimized GM-CSF to HPV16 E7 DNA., PMID:34247810
Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer., PMID:33949155
ePCL Electrospun Microfibrous Layers for Immune Assays: Sensitive ELISA for the Detection of Serum Antibodies Against HPV16 E7 Oncoprotein., PMID:33842749
Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour model., PMID:33627686
Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors., PMID:33485370
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody., PMID:33468698
Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens., PMID:33335126
PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model., PMID:33108473
A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)., PMID:32918586
Epitope Mapping and Computational Analysis of Anti-HPV16 E6 and E7 Antibodies in Single-Chain Format for Clinical Development as Antitumor Drugs., PMID:32640530
A preliminary study on the immune responses of HPV16-E7 by combined intranasal immunization with lymphotoxin., PMID:32627150
Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine., PMID:32554612
Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18., PMID:32214362
Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies., PMID:32204370
Antibodies against human papillomavirus proteins in Barrett's dysplasia and intramucosal esophageal adenocarcinoma., PMID:32170783
A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer., PMID:32151670
Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment., PMID:32111835
CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies., PMID:31964784
FLT3L and granulocyte macrophage colony-stimulating factor enhance the anti-tumor and immune effects of an HPV16 E6/E7 vaccine., PMID:31881013
The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells., PMID:31806970
TCR sequencing paired with massively parallel 3' RNA-seq reveals clonotypic T cell signatures., PMID:31745340
A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3., PMID:31576684
Prognostic value of posttreatment HPV-specific antibodies in patients with oropharyngeal tumors., PMID:30986340
Post-treatment human papillomavirus antibody kinetics in cervical cancer patients., PMID:30955486
Nanobody against the E7 oncoprotein of human papillomavirus 16., PMID:30849663
Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women., PMID:30755156
Extracellular overproduction of E7 oncoprotein of Iranian human papillomavirus type 16 by genetically engineered Lactococcus lactis., PMID:30678667
Increased Response of Human T-Lymphocytes by Dendritic Cells Pulsed with HPV16E7 and Pleurotus sajor-caju-β-glucan (PBG)., PMID:30593739
Nuclear lactate dehydrogenase A senses ROS to produce α-hydroxybutyrate for HPV-induced cervical tumor growth., PMID:30356100
Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer., PMID:30353680
Oral immunization with recombinant Lactococcus lactis NZ9000 expressing human papillomavirus type 16 E7 antigen and evaluation of its immune effects in female C57BL/6 mice., PMID:30192395
Small Heat Shock Proteins B1 and B6: Which One is the Most Effective Adjuvant in Therapeutic HPV Vaccine?, PMID:30171788
Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice., PMID:30131378
Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers., PMID:30054333
A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer., PMID:30026865
For research use only. Not for human or drug use.
